Menadione-induced apoptosis: roles of cytosolic Ca(2+) elevations and the mitochondrial permeability transition pore

J Cell Sci. 2002 Feb 1;115(Pt 3):485-97. doi: 10.1242/jcs.115.3.485.

Abstract

In normal pancreatic acinar cells, the oxidant menadione evokes repetitive cytosolic Ca(2+) spikes, partial mitochondrial depolarisation, cytochrome c release and apoptosis. The physiological agonists acetylcholine and cholecystokinin also evoke cytosolic Ca(2+) spikes but do not depolarise mitochondria and fail to induce apoptosis. Ca(2+) spikes induced by low agonist concentrations are confined to the apical secretory pole of the cell by the buffering action of perigranular mitochondria. Menadione prevents mitochondrial Ca(2+) uptake, which permits rapid spread of Ca(2+) throughout the cell. Menadione-induced mitochondrial depolarisation is due to induction of the permeability transition pore. Blockade of the permeability transition pore with bongkrekic acid prevents activation of caspase 9 and 3. In contrast, the combination of antimycin A and acetylcholine does not cause apoptosis but elicits a global cytosolic Ca(2+) rise and mitochondrial depolarisation without induction of the permeability transition pore. Increasing the cytosolic Ca(2+) buffering power by BAPTA prevents cytosolic Ca(2+) spiking, blocks the menadione-elicited mitochondrial depolarisation and blocks menadione-induced apoptosis. These results suggest a twin-track model in which both intracellular release of Ca(2+) and induction of the permeability transition pore are required for initiation of apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Amino Acid Chloromethyl Ketones / pharmacology
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Antifibrinolytic Agents / pharmacology
  • Antimycin A / pharmacology
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Bongkrekic Acid / pharmacology
  • Calcium / metabolism*
  • Calcium Signaling / physiology*
  • Caspase 3
  • Caspase 9
  • Caspases / metabolism
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • Chelating Agents / pharmacology
  • Cysteine Proteinase Inhibitors / pharmacology
  • Egtazic Acid / analogs & derivatives*
  • Egtazic Acid / pharmacology
  • Fluoresceins / pharmacology
  • Fluorescent Dyes / metabolism
  • Membrane Potentials / physiology
  • Mice
  • Mitochondria / metabolism*
  • Pancreas / cytology
  • Pancreas / drug effects*
  • Vasodilator Agents / pharmacology
  • Vitamin K 3 / pharmacology*

Substances

  • Amino Acid Chloromethyl Ketones
  • Anti-Bacterial Agents
  • Antifibrinolytic Agents
  • Chelating Agents
  • Cysteine Proteinase Inhibitors
  • Fluoresceins
  • Fluorescent Dyes
  • Vasodilator Agents
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • Bongkrekic Acid
  • 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester
  • Egtazic Acid
  • Antimycin A
  • Vitamin K 3
  • Casp3 protein, mouse
  • Casp9 protein, mouse
  • Caspase 3
  • Caspase 9
  • Caspases
  • Acetylcholine
  • Calcium
  • fluorexon